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Cadmium is a cumulative environmental pollutant. Forthe general population mainly exposed by the oral
route and through tobacco smoke inhalation, the kidney is the critical organ. Belgium is the principal
producer ofcadmium in Europe, and certain areas ofthe country are polluted by cadmium mainly because
of past emissions from nonferrous industries. Preliminary studies carried out in one polluted area have
suggested that environmental pollution might lead to an increased uptake ofcadmium by the human body
and possibly to health effects. Thus, a large-scale morbidity study has been initiated to assess the validity
of this hypothesis. The present paper describes the protocol of this study. Its main objectives are to
determine to what extent environmental exposure to cadmium resulting from industrial emissions may
lead to accumulation of the metal in the human organism; to establish whether or not environmental
exposure may induce renal changes and/or influence blood pressure; and to assess the acceptable internal
dose of cadmium for the general population. The study design takes advantage ofthe fact that biological
indicatorsofexposure, bodyburden, andearlynephrotoxiceffectsofcadmiumareavailable, whichincrease
the likelihood ofdetecting a cause-effect relationship.
Introduction
Cadmium Metabolism and Toxicity
Cadmium is an occupational and environmental pol-
lutant that has raised great concern duringthe last dec-
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ade. Its industrial production started at the beginning
of this century, and since then it has almost doubled
every 10 years at least up to 1970 (1). The opportunities
for recycling cadmium are limited in view of the dis-
persive nature of several of its major uses; therefore,
the metal progressively accumulates in the environ-
ment. In Sweden, the average concentration of cad-
mium in winter wheat has increased during the twen-
tieth century by 100% (2). An important toxicologic
feature ofcadmiumisitsexceptionallylongbiologichalf-
life in the human organism (10 to 30 years).
Excessive exposure to cadmium has been linked with
the development of respiratory insufficiency (occupa-
tional exposure), renal disturbances and osteomalacia
(environmental and occupational exposure) (3). The role
ofcadmiuminthe developmentofhypertensionremains
uncertain.
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of various types of cancer. Although cadmium is car-
cinogenic in animals under certain exposure conditions
and may enhance the occurrence of lung and possibly
prostate cancer in workers exposed to high airborne
concentrations, there is no current epidemiologic or ex-
perimental evidence substantiating that exposure to
cadmium via food may be associated with an increased
risk ofcancer (4).
It is generally accepted that for the general popula-
tion mainly exposed by the oral route and possibly
through inhalation oftobacco smoke, the kidney is the
critical organ (i.e., the organ in which the first adverse
effects occur). One ofthe earliest signs ofcadmium ne-
phropathy is an increased proteinuria resulting from a
decreased tubularreabsorption oflowmolecularweight
proteins (e.g., P2-microglobulin, retinol-binding pro-
tein)andpossiblyalsoanincreasedglomerularifitration
ofhighmolecular weight proteins (e.g., albumin, trans-
ferrin) (3,5).
Studies carried out in workers exposed to cadmium
mainly byinhalation have led to the proposal that ifthe
level in the renal cortex does not exceed 200 mg Cd/kg
(wet weight), corresponding to aurinary cadmium con-
centration of about 10 Rg/g creatinine, the probability
of detecting renal damage is low (6,7). It should be
stressed, however, that this conclusion, based on stud-
ies performed on occupationally active male subjects,
might underestimate the risk for other groups in the
general population, particularly for older persons with
declining renal function. The results of a few prelimi-
nary epidemiologic studies carried out in Belgium and
summarized later in this paper tend to support this hy-
pothesis.
Environmental Pollution by Cadmium in
Belgium
Belgium is an important producer ofcadmium (about
one-fourth of the European production), and certain
areas ofthe country (e.g., the Meuse valley near Liege
andtheruralnorthern partofthe Kempen) arepolluted
bycadmium, mainlybecauseofpastemissionsfromnon-
ferrousindustries. Forexample, inLiege, between 1972
and 1977 when three large zinc and/or cadmium pro-
ducing plants were still in operation, the 50 and 95 per-
centiles ofthe daily airborne concentration ofcadmium
near the urban center amounted to 18 and 165 ng/m3
respectively (8). In an industrial area with low envi-
ronmental cadmium contamination (Charleroi), the 95
percentile of the daily airborne concentration of cad-
miumneverexceeded30ng/m3. Between 1978and 1987,
the cadmium concentrations in soil and in grass in the
Liege area ranged from 4 to 39 mg/kg (dryweight) and
from 0.5 to 25 mg/kg (dry weight), respectively;
whereas the corresponding values in the control indus-
trial area (Charleroi) ranged from 0.5 to 1 mg/kg (dry
weight) andfrom < 0.5to2mg/kg(dryweight). Recent
measurements have been performed in the northern
part ofthe Kempen (N-Kempen) where two important
primary zinc smelters have operated since 1888 and one
zinc smelter was in operation from 1904 to 1972. These
findings confirmed the environmental pollution by cad-
mium in this rural area (measurements perfonned by
the Institute of Hygiene and Epidemiology, Brussels;
Institut de Recherches Chimiques, Tervuren; Lisec-
Studiecentrum voor Ecologie en Bosbouw, Bokrijk).
For example, between 1984 and 1987, the 50 percen-
tile ofthe daily airborne concentration ofcadmium was
below 10 ng/m3, but the 95 percentile amounted to 40
ng/m3. Between 1981 and 1986 the cadmium concentra-
tionsofgrassrangedfrom0.13to29mg/kg(dryweight).
The cadmium contamination ofthe top-layer soil (0-25
cm) from 155 kitchen-gardens was measured in the
years 1983 and 1984; the levels ranged from 0.5 to 24
mg/kg (dry weight), and 41% of the samples had cad-
mium levels > 3 mg/kg (dry weight). Well water from
that area was also found to be contaminated by cad-
mium. Duringtheyears 1983to 1984, the cadmiumcon-
centration of water samples from 2410 wells (> 95%
used as drinking water) ranged from 0.05 to 400 Fg/L
(50 and 90 percentiles amounting to 4.3 and 25 ,ug/L,
respectively); 45% and25% ofthe sampleshadcadmium
levelsexceeding5and 10 p,g/L, respectively. InBelgian
rural areas that are not polluted the 95 percentile of
daily airborne cadmium level is lower than 10 ng/m0,
and the background cadmium contamination of grass
and soil does not exceed 0.2 and 1 mg/kg (dry weight),
respectively.
Preliminary Studies on Environmental
Exposure to Cadmium in Belgium and Its
Health Effects
The environmental exposure of the Belgian popula-
tion to cadmium is high compared with other countries
(9). In a World Health Organization (WHO) collabora-
tive study carried out in 1981 involving teachers from
10 countries, the median cadmium concentration in
blood ranged from 1.2 ,ug/L for Japan and Belgium to
less than 0.5 p/L in Israel. Also, three studies were
undertaken in the Liege area to assess whether or not
the environmental pollution by cadmium led to an in-
creaseduptakebytheinhabitantsandpossiblytohealth
effects.
In the first study carried out in 1978 and 1979 (10) it
was found that the blood and urine levels of cadmium
in a group ofnonsmoldng elderly women (n = 60), who
had spent most of their life in the Liege area and had
never been occupationally exposed to cadmium, were
higher than those found in a group ofwomen (n = 70)
ofthe sameageand socio-economic statuswhohadlived
in the control industrial area (Charleroi) that was less
polluted by this metal. The urinary excretion of total
protein, aminoacids, 32-microglobulin and albumin fol-
lowed the same trend as that ofcadmium.
Following these preliminary observations, a mortal-
ity study was undertaken (11). It was found that al-
though the overall mortality was not markedly differ-
ent, the standardized mortality ratios (SMR) and the
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proportional mortality rates (PMR) from nephritis and
nephrosis for the years 1969 to 1976 were higher in
Liege than in Charleroi orin Belgium as awhole (SMR:
Belgium 100, Charleroi 102, Liege 196; and PMR: Bel-
gium 3.3, Charleroi 3.0, Liege 6.0). Since the increased
mortality rate for renal diseases was observed in both
males and females, the influence of environmental fac-
tors other than occupation was suggested. Further-
more, a 1980 epidemiologic study on analgesic nephro-
pathy (a frequent cause of end-stage renal disease in
certain areas of Belgium) did not show a difference in
the prevalence ofthe disease between Liege and Char-
leroi (12), suggesting that the higher SMR by nephritis
and nephrosis in Liege did not result from a difference
in the consumption of analgesics between the two re-
gions.
To confirm that the cadmium body burden of the
Liege inhabitants wasreallyincreased, as suggested by
the results oftheurinaryexcretion ofcadmium, astudy
of autopsies was undertaken (13). It was found that in
all age groups, the persons who had lived in the Liege
area had accumulated more cadmium in their renal cor-
tex and liver than did residents from other areas of
Belgium (mainly from the southern provinces). The
same trend was found in males and females. Exami-
nation of the medical records and/or an inquiry to the
next of kin indicated that this difference did not result
from differences in occupational exposure or smoking
habits between the groups.
Although the results ofthese three studies (10,11,13)
suggest a possible health effect of environmental ex-
posure to cadmium, they must still be interpreted cau-
tiously. These studies have beenperformed in the same
area (Liege), and the influence ofanother unknown fac-
torinterfering withrenalfunctionremains apossibility.
To further assess the hypothesis that environmental
pollutionbycadmium inBelgiummayhaveledtohealth
effects, it was considered necessary to undertake an-
othermorbidity studyoflargerscalethanthepreceding
one which involved several areas of the country. The
present report describes the methodology of this col-
laborative study.
Objectives of the Present Study
The main objectives of the study were to determine
to what extent environmental exposure to cadmium re-
sulting from industrial emissions may lead to accumu-
lation ofthe metal in the human organism; to establish
whether or not environmental exposure may induce
renal changes and/or influence blood pressure; and to
assess the acceptable internal dose of cadmium for the
general population. In view of our current knowledge
of the metabolism and the nephrotoxic effects of cad-
mium, the internal dose of cadmium was assessed by
measuring its levels in blood and urine, while the de-
termination of creatinine clearance and of urinary ex-
cretion of specific proteins were used as indicators of
renal effects.
The study was designed so that additional objectives
complementary to those cited above could be pursued,
i.e., the assessment of the possible impact of environ-
mental exposure to lead on renal function and blood
pressure; the identification of endogenous and exoge-
nous factors that influence the internal dose oflead and
cadmium, blood pressure, and renalfunction; and even-
tually an assessment of the health significance of the
morbidity data collected in the framework ofthis study
by an independent analysis of the mortality from car-
diovascularandrenaldiseasesintheareasinvestigated.
Selection of the Areas
Attempts were made to select areas differently pol-
luted by cadmium and also to match each polluted area
with at least one less polluted or control area with re-
gard to the socioeconomic environment. Four areas
were selected: a) One industrial area (Liege) was pol-
lutedmainlybecause ofindustrial emissions ofcadmium
(the last cadmium producing plant was closed in 1981);
the areahas asurface ofabout 100km' and apopulation
density of 2272 persons/km2, and steel production re-
mains an important industrial activity in this area. b) A
second industrial area (Charleroi) was not polluted by
cadmium but had iron foundries in operation; the area
is spread over 130 km2 and has a population density of
2014 persons/km2. c) A rural area (N-Kempen), located
near two nonferrous smelters, has a surface approxi-
mately 200 km2 with a population density 280 persons/
km2. d) A control rural area (Hechtel-Eksel) has a sur-
face area approximately 75 km2 with a population den-
sity of 125 persons/km (Fig. 1).
Population Selection
In view ofthe distribution characteristics ofthe var-
ious measurements, the examination of250 to 300 per-
FIGURE 1. Areas selected for the study of the health effects of en-
vironmental exposure to cadmium in Belgium.
CADMIBEL STUDY
285LAUWERYS ET AL.
sons in each ofthe four areas was considered sufficient
to detect with an a error of 5% and a i error of 10%,
a 10% difference in the protein excretion, a 5% differ-
ence in creatinine clearance, or a 5 mm Hg difference
insystolicpressureanda3mmHgdifferenceindiastolic
pressure.
Hence, it was finally decided to examine at least 300
subjects (150 males and females) in each area, equally
distributed over the three age groups 20 to 39, 40 to
59, and 60 to 79 years, respectively. At least 600 sub-
jects have thus been examined in the polluted areas
(Liegeand N-Kempen) and600inthelesspollutedareas
(Charleroi and Hechtel-Eksel). Although it was in-
tended to select a similar number of male and female
individuals ineach age group, forpracticalreasons sam-
pling was based on households defined as all subjects
living at the same address.
In each area a sample ofat least 200 households was
randomly selected. All family members between the
ages of20 and 80 were eligible for the study as long as
the number ofindividuals (n = 50) needed in each sex
and age group had not been reached. When 50 individ-
uals had been identified in one or more of the six sex-
age strata, only the family members belonging to the
subgroups whose quota had not yet been satisfied were
selected. Households whose head members were not of
Belgian nationality were excluded from the sample.
Several methods were used to gain local support for
the study and motivate the participants. All local civil
authorities (mayor and aldermen), health inspectors,
generalpractitioners, and healthprofessionals were ap-
proached. Advertisements appeared in local newspa-
pers and were broadcasted on radio and television. A
letter of invitation was sent to all eligible families. All
participants were informed oftheirpersonal results via
their general practitioner.
Experimental Protocol
Field Study
The field study was spread over 4 years and was
carried out by ten specially trained observers (nurse or
social worker). Two areas were always examined at the
same time.
Each household was visited twice by the same ob-
server. Thefirsthome visitconsisted offiveconsecutive
blood pressure readings (phase 5 diastolic pressure),
obtained with a standard sphygmomanometer in the
sitting position followed by a pulse rate count and a
measurement of height and body weight. The partici-
pants were given a self-administered questionnaire and
a wide-neck metal-free polyethylene container for a 24-
hr urine collection. They were carefully instructed, in
writing, about the procedure for collecting the urine
and storing the containers between voidings in order to
prevent metal contamination. The questionnaire in-
quiredabouttheparticipants'medicalhistory, theircur-
rentandpastoccupations, smokinghabits, consumption
ofalcohol, locally grown vegetables and wellwater, and
drugintake. (A translation ofthe questionnaire in Eng-
lish is available on request.)
At the second visit 1 week later, the questionnaire
and a recent 24-hrurine sample were collected, and the
measurementsofbloodpressure, pulserate, height, and
body weight were repeated. Each subject was thus
characterized by the mean of ten blood pressure mea-
surements and by two determinations of pulse rate,
height, and body weight.
At one ofthe home visits, preferablythe first, afresh
urine sample was obtained afterthe blood pressure and
pulse rate measurements had been performed. Four
milliliters (for ,2-microglobulin measurement) were im-
mediatelytransferred toatube containing0.4mL phos-
phate buffer 1 M, pH 7.6, containing 0.2% NaN3. For
the preservation ofthe 24-hr urine samples, NaN3 10%
(3 mL/container) was used. The volume and the pH of
the 24-hr urine samples and the pH of the spot-urine
samples were measured in the field centers and indi-
cated on the containers.
On a separate occasion, but usually within 1 week of
the urine collection, a physician visited the participants
and withdrew 20 mL venous blood with a syringe. The
sample was divided in two aliquots of 4 mL (2 tubes
with anticoagulant, 0.1 mL Na2-EDTA 10%), and the
remainder was kept in two empty tubes for separation
of serum in the field centers.
All blood and urine samples were kept at 4°C. These
samplesweretransportedincoolingboxesfromthefield
centers to the laboratories once a week.
All laboratory materials (tubes, urine containers, sy-
ringes, and needles) and solutions (buffer, NaN3,
EDTA) were checked for contamination by cadmium,
lead, selenium, zinc, copper or calcium. The acceptable
background contamination of materials and solutions
had to be < 0.05 ,ug/L for cadmium, < 2 ,g/L for lead,
< 2 ,ug/L for selenium, < 10 ,ug/L for zinc, < 0.5 ,ug/L
for copper, and < 0.1 mg/L for calcium.
Biological Analyses
The following measurements were performed in the
twolaboratoriesinvolvedinthestudy: onwholeblood
lead, cadmium, zinc-protoporphyrin, and selenium; on
serum-creatinine, alkaline phosphatase, -y-glutamyl-
transpeptidase, total cholesterol, HDL cholesterol, cal-
cium, magnesium, zinc, ferritin, and ,B2-microglobulin;
on 24-hr urine-creatinine, cadmium, calcium, sodium,
potassium, copper, total amino acids, total protein, 12-
microglobulin, retinol-binding protein, albumin, N-ace-
tyl-1-glucosaminidase, and reagent strip analysis; on
spot-urine-creatinine, cadmium, 132-microglobulin,
and reagent strip analysis.
The determination ofcadmium, lead, and selenium in
whole blood, and ofcadmium and copper in urine were
performed by electrothermal atomic absorption spec-
trometry (Perkin-Elmer Zeeman-3030 orZeeman-5100)
using thestabilized-temperature-platform-furnace (Cd,
Pb, Se) orthefurnacewall(Cu)techniquescoupledwith
a Zeeman-effect background correction system. The
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method ofexternalstandardlineinawholebloodmatrix
was used for trace metal analysis in whole blood, while
the method ofstandard additionwasusedforurine. The
concentration of zinc in serum was determined accord-
ing to Kelson and Shamberger (14), using the method
of deproteinization with trichloroacetic acid combined
with flame atomic absorption spectrometry (Perkin-El-
mer Model 305).
Zinc-protoporphyrin (ZPP)inbloodwasmeasured us-
ing a hematofluorimeter (Aviv Associates, Lakewood,
NJ). The concentration ofP2-microglobulin and ferritin
in serum and that of ,B2-microglobulin, retinol-binding
protein (RBP) and albumin in urine were determined
usinganonisotopicimmunoassaybased onlatexparticle
agglutination (15).
Acolorimetricmethodwasusedforthedetermination
of total a-N-amino-aciduria using picrylsulfonic acid
(16). Total proteinuria was determined on urine, after
overnight dialysis, using Folin's reagent and bovine
serum albumin as reference protein (17). The activity
ofN-acetyl-p-glucosaminidase (NAG) in urine was de-
terminedaccordingtothefluorimetricmethodofTucker
et al. (18). Creatinine in serum and urine (19), magne-
sium (20), alkaline phosphatase (21), y-glutamyltran-
speptidase (yGT) (22), total cholesterol (23) and HDL
cholesterol(24)inserumweredetermined onaCOBAS-
BIO centrifugal analyzer (Roche Diagnostics). Calcium
in serum and urine was analyzed by a complexometric
titration method (25) on a Corning 940 Calcium Ana-
lyser. Sodium and potassium in urine were measured
by flame photometry (KLiNa-Beckman Instrument)
(26).
Quality Control
Training of the Observers and Blood
Pressure Measurements
The trainees were explained the rationale and meth-
odology of blood pressure measurements, were shown
a videotape (Measuring Blood Pressure, Production n°
B, 132, TheAudio-visual Centre, UniversityofLondon,
11 Bedford Square, London WC1, 1973) showing a fall-
ing mercury column, and they obtained experience us-
ing a regular sphygmomanometer at home for 1 week.
They were then tested in two phases: they again re-
corded the pressures from the videotape and were fi-
nally tested by using stethoscopes having two pairs of
earpieces onlivesubjects. Topassthetestallvideotape
readings had to be within 10% ofthe standard, and all
measurements in the live subjects had to be to within
10% ofthe simultaneous pressure determinations by an
experienced observer (27).
were defined for duplicate measurements, and a series
of measurements was repeated when the precision or
the results of the corresponding standards (accuracy)
fell outside the limits specified in Table 1.
Before the start of the study and during its course,
the two laboratories participated in several external
quality control programs that concerned the following
measurements: cadmium and lead in blood (UK Exter-
nal Quality Assessment Scheme organized by the Wolf-
son Research Labs, Queen Elisabeth Medical Centre,
Birmingham, England); zinc and selenium in serum,
lead, andcadmiuminbloodandcadmiuminurine(Trace
Element QualityControl Scheme organizedbythe Rob-
ensInstitute, UniversityofSurrey, Guildford, UK);and
creatinine, alkaline phosphatase, -y-glutamyltranspep-
tidase, total cholesterol and calcium in serum (Belgian
Quality Control Scheme supervised by the Ministry of
Health).
Furthermore, for some analyses (lead, cadmium, and
ZPP in blood; zinc, ferritin, and 032-microglobulin in
serum; cadmium, copper, creatinine, P2-microglobulin,
andretinol-bindingproteininurine), 10%ofthesamples
were analyzed in the two study laboratories. When the
resultsofonesampledeviatedmorethan10%, thewhole
series was reanalyzed in both laboratories.
Data Processing and Statistical
Analysis
Coding the questionnaire and clinical examination
sheet was performed by trained technicians who also
entered the data into the computer. For the purpose of
Table 1. Acceptance limits for precision ofduplicate
measurements and accuracy.
Sample Analyte
Whole blood Cd (- 2 Rg/L)
(> 2 ,ug/L)
Pb
Se
ZPP
Serum
Urine
Biological Analyses
Most ofthe analyses were performed in duplicate us-
ing internal calibration standards and, when available,
certified reference standards were run along with each
series ofstudy samples. Acceptable limits for precision
Zn
Creatinine
32-Microglobulin
Alkaline phosphatase
Ca
y-GT
Ferritin
Cholesterol
Magnesium
Cd
Cu
Amino acids (total)
Proteins (total)
12-Microglobuiin
RBP
Albumin
Na
K
Ca
Creatinine
NAG
Precision, %
< 10
< 5
< 5
< 5
< 5
< 5
< 4
< 10
< 3
< 2
< 3
< 10
< 4
< 3
< 5
< 5
< 5
< 10
< 10
< 10
< 10
< 2
< 2
< 2
< 2
< 5
Accuracy, %
+ 15
+ 10
-- 5
+ 10
-'- 10
+ 5
+ 5
+ 10
+ 5
+ 2
± 5
+ 10
+ 4
+ 5
+ 5
+ 5
+ 10
+ 10
+ 10
+ 10
+ 10
+ 4
+ 4
+ 2
+ 3
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quality assurance, 10% ofthe questionnaires coded by
one technician was selected at random and coded again
by another technician and vice versa. All results ofthe
biological measurements, questionnaires, and clinical
examination that were entered into the computer were
verified against the original data. Algorithms based on
the answers to the questionnaire have been defined to
characterize smoking habits and alcohol consumption
and to identify subjects with current or past occupa-
tional exposure to heavy metals, those under current
and/or past medication known to interfere with blood
pressure or renal function (e.g., antihypertensive
drugs, diuretics, analgesics, contraceptive pill), and
those with recent and/or past history of diabetes mel-
litus or of diseases of the cardiovascular or renal sys-
tems. The statistical analysis will be performed using
the procedure ofmultivariate analysis provided by the
SAS system (28). If necessary, comparisons of group
means and regression analyses will be performed after
normalizingthe distribution ofbiological measurements
by a logarithmic transformation.
Practical Organization of the Study
The progress of the field and laboratory work was
supervised by a scientific committee composed of sci-
entists belonging to the four research units. Three-
month-interval reports were submitted to a steering
committee composed ofrepresentatives ofthe agencies
that funded the study.
Discussion
With a few exceptions the majority ofepidemiologic
studies onthehealtheffects ofenvironmentalpollutants
haveattemptedtoassesstherelationshipsbetweenvar-
ious external indicators ofpollution (presence of emis-
sion sources, results of environmental monitoring net-
work) and morbidity (clinical signs) and/or mortality
data. This kind of approach suffers from many limita-
tions. Indeed, current and/or past exposure to pollu-
tants can only be estimated on a population basis. Fur-
thermore, diagnosed clinical entities are late
manifestations ofphysio-pathological processes, the ev-
olution of which to diseases may have been influenced
by various exogenous and endogenous factors. With
such anapproach, environmental pollutantscanbeiden-
tified as etiologic agents of pathologic conditions only
when their role is overwhelming by comparison with
that ofother factors orwhen the time interval between
exposure and diseases (latency period) is not too long.
But environmental pollution is rarely of such intensity
that its clinical effects are rapidly apparent. Further-
more, since many diseases are multifactorial, the fa-
voringrole ofenvironmental factors maybeeasilyover-
looked with anepidemiologic approach based on acrude
assessmentofexposuretoenvironmentalpollutantsand
a search for late effects (diseases, causes ofdeath).
These difficulties can be overcome if assessment of
exposure is carried out on an individual basis (e.g.,
through the use ofbiological monitoring methods) and
if early biological effects are selected as health indica-
tors. This individual approach offers the advantage of
preventing the dilution effect associated with the use
of external exposure parameters (ambient pollution).
Biologicalmonitoringmarkedlyreducestheuncertainty
in the assessment ofindividual exposure to pollutants.
Furthernore, theusuallyshortertimeintervalbetween
the occurrence of an excessive body burden and the
development ofearly biological effects prevents the in-
terference ofvarious factors that subsequently may in-
fluence the evolution to clinical disease and mask the
contribution ofenvironmental pollution.
Unfortunately, our limited knowledge on the meta-
bolicfateofenvironmentalpollutantsinthehumanbody
andtheirmechanism ofactionrestricts the applicability
of such an approach. Cadmium is a remarkable excep-
tion. Biological indicators are available to estimate cur-
rent (cadmium in blood) and lifetime-integrated expo-
sure (cadmiuminurine) and to detectits earlyinfluence
on its main target organ, the Iddney. The design ofthe
present epidemiologic study has taken benefit of this
knowledge and is a good example ofthe importance of
theinterplaybetweenepidemiologists andbiologistsfor
abetter assessment ofthe potential health impact ofan
environmental pollutant.
The advantage ofmeasuring early preclinical effects
stems not only from the reduction ofthe latent period,
whichincreasesthelikelihoodofdetectingacause-effect
relationship, but probably also from the reduction of
selection-bias influence (e.g., sick persons may decide
to move from an industrially polluted area). With cad-
mium, it is possible to assess the body burden of each
participant by a biological measure that permits re-
searchers to study the correlation between individual
lifetime-integrated exposure and the riskofadverse ef-
fects without maldng any assumption on past environ-
mental pollution, for which monitoring data may not
necessarily be available. The method ofpopulation se-
lection (sampling on households) also offers several ad-
vantages (29) over individual sampling: a) it is more
practicalsinceseveralpersonscanbevisitedatthesame
address, b) it usually has a higher participation rate, c)
itpermitsinvestigatorstoperformbloodpressureread-
ings in more basal conditions, and d) it allows them to
study, in a subset of the examined population, the in-
fluence offamilialaggregationoncertainmeasurements
(e.g., bloodpressure) and environmentalfactors oncad-
mium exposure (e.g., consumption ofwell water).
One must, however, recognize that the design ofthe
present study has also some limitations that must be
kept in mind when interpreting the results. If the bi-
ological measures of exposure are specific for the pol-
lutant under study, the early indicators of effect are
usually organ specific but not pollutant specific. This
approach, therefore, shouldtakeintoaccountotherpos-
sible interfering factors. Depending on our current
knowledge, these factors may be assessed through bi-
ological measurement (e.g., exposure to lead) or, more
classically, through the use of a detailed questionnaire
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(e.g., consumption of drugs and tobacco, occupation).
Furthermore, the health significance ofthe earlymark-
ers ofnephrotoxicity is not yet fully established. How-
ever, there is some evidence from a study carried out
oncadmiumworkersthatapersistentincreasedurinary
excretionofproteinsmaybepredictiveofanaccelerated
age-related decline of renal function (reduction of glo-
merular ifitration rate), but the level of protein excre-
tion at which the risk is significantly increased is still
unsettled (30).
An important aspect of a large-scale collaborative
study spread over severalyearsistheneed forrigorous
quality control programs. Great time and effort have
been spent before and during the study to define, in
detail, all the quality control programs to be imple-
mented and to check that their results meet the set
objectives.
Thedesignofthis studyshouldallowustoconfidently
assess whether or not the body burden of cadmium in
groups of the general population who have resided in
environmentally polluted areas entails some health risk
and also possibly determine the internal dose of cad-
mium at which the risk ofadverse effects is increased.
This investigation was supported by the Ministry of Health and
Social Affairs, the Ministry ofthe Flemish Community, the Ministry
ofthe Brussels Region, the Fund forMedical Scientific Research, and
the International Lead Zinc Research Organization.
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